The etiology of schizophrenia (SCZ) is multifactorial and complex. Scientists employed animal models, human post-mortem tissue, imaging, bioinformatics, and recently human induced pluripotent stem cell (hiPSC)-based modeling to dissect the underlying multifaceted mechanisms of the disease. The emerging consensus is that cortical pathology is one of the fundamental features of schizophrenia (Selemon, 2001; Selemon and Zecevic, 2015; Parnanzone et al., 2017; Di Biase et al., 2019). The neocortex consists of around 80% of glutamatergic excitatory pyramidal neurons and 20% of GABAergic inhibitory interneurons (Harris and Shepherd, 2015; Lodato and Arlotta, 2015; Tatti et al., 2017; Musall et al., 2023). Mounting evidence suggests that aberrant connectivity of cortical macrocircuitry and microcircuitry plays a pivotal role in SCZ, especially excitation/inhibition (E/I) imbalance at the molecular, cellular, cell-type, and regional levels (Yizhar et al., 2011; Lisman, 2012; Marin, 2012; Gao and Penzes, 2015; Sohal and Rubenstein, 2019; Liu et al., 2021). The imbalance in excitatory and inhibitory information can cause disruption in sensory and working memory (Casanova et al., 2007; Opris and Casanova, 2014). The knowledge derived from the article collection in this Research Topic will be of help for understanding and unraveling the pathophysiology of SCZ under the framework of E/I imbalance.
At the molecular and cellular level, dysfunction of corticolimbic glutamatergic neurotransmission plays a critical role in the manifestations of schizophrenia (Coyle, 1996; Paz et al., 2008; Egerton et al., 2020). Glutamatergic neurons represent the primary excitatory afferent and efferent systems innervating the cortex, limbic regions (e.g., hippocampus and amygdala), and striatum (Coyle, 1996; Moghaddam, 2003). This orchestrates intricate interplays amongst neuronal networks (e.g., glutamatergic, GABAergic, dopaminergic, serotonergic neurotransmission, etc.). Dysfunction in one of those neuronal networks could alter an E/I balance (Belmer et al., 2016; Hayashi-Takagi, 2017; Sonnenschein et al., 2020). Let us now focus on the units of neuronal networks, i.e., neuronal synapses. It is well documented that synaptopathy underlies a variety of psychiatric disorders (Hayashi-Takagi, 2017; Obi-Nagata et al., 2019; Friston, 2023). Our study based on hiPSC modeling showed that an array of genes involving glutamatergic, GABAergic, dopaminergic, and cholinergic synapses are downregulated in the neurons derived from clozapine-responsive SCZ patients (e.g., GRIN2A, GRM1, VGLUT3, VGLUT2, GNB2, ADCY1, ADCY2, ADCY5, ADRBK1, GABBR2, GABBR3, GAT1, VGAT, GAD1, GABARAPL2, DRD1, CAMK2A, CAMK2B, PPP2R2C, PPP2CB, PPP2R5B, MAOA, MAPK11, KIF5A; CHRM3, KCNQ2). The majority of those genes are restored by clozapine, especially the function of NMDA receptors (Hribkova et al., 2022). It was also observed a significant reduction in VGLUT1/PSD95-positive synapses in SCZ neurons (Hribkova et al., 2022). PSD95 plays critical roles in maintaining the balance between excitatory and inhibitory synapses, synapse development, and synaptic plasticity (Zeng et al., 2016; Lambert et al., 2017; Smith et al., 2017). In this Research Topic, Chen et al. report that defective dendritic spines and autism-like behaviors observed in the Fragile X messenger ribonucleoprotein 1 (Fmr1) knockout mice are rescued by dihydrotestosterone (DHT), whereby DHT increases PSD95 expression by abating the Fragile X messenger ribonucleoprotein (Fmrp)-mediated miR-125a/RISC inhibition of PSD95 productions. Moreover, neuronal extracellular vesicles (EVs) are also a key player in neuronal synapses. CD63 is one of the EV proteins and facilitates vesicular trafficking through endosomal pathways. Hendricks et al. find that Tsp42Ee and Tsp42Eg (Tsps), CD63 homologs in Drosophila, influence the synaptic cytoskeleton and membrane composition by regulating Futsch loop formation and synaptic levels of SCAR and PI(4,5)P 2. Tsps influence the synaptic localization of several vesicle-associated proteins including Synapsin, Synaptotagmin, and Cysteine String Protein. In a review article, Jiao et al. delineate the roles of neuronal EVs in cellular homeostasis, intercellular communication, and phenotypic changes in the recipient cells via sophisticated machineries. Aberrant EVs cause neuropathy and lead to neurological disorders, which echoes the EVs' role in SCZ (Wang et al., 2022). Others and we also observed abnormalities in EVs in SCZ. A study reported that peripheral EVs in psychotic patients contain higher levels of proteins involving the regulation of glutamatergic synaptic plasticity (Tunset et al., 2020). Our study showed that some of the genes responsible for synaptic vesicle cycle (e.g., VGLUT2, VGLUT3, VGAT, CPLX2, RAB3A, STX1B1, and ATP6V1A) are down-regulated in clozapine-responsive SCZ neurons (Hribkova et al., 2022).
Furthermore, synaptic ion channels also play a pivotal role in shaping synaptic communication and plasticity (Voglis and Tavernarakis, 2006; Burke and Bender, 2019) and accumulating data suggest that polymorphisms and mutations in ion channels link to the susceptibility or pathogenesis of psychiatric diseases (Imbrici et al., 2013). Our study also reveals that a score of genes encoding ion channels [e.g., SLC4A4, SLC32A1, SLC13A4, SLC1A4, SLC17A8, SLC17A6, SCN2A, ATP1B1, SCN3A, ATP1A2, ATP1A3, SLC6A1, HCN4, KCNK10, KCNB1(Kv2.1), KCNH8 (Kv12.1), KCTD2, ATP1B1, KCNQ2 (Kv7.2), ATP1A2, ATP1A3, TMEM38A, KCNG1 (Kv6.1), KCNF1 (Kv5.1), KCNJ4 (Kir2.3), CACNG5, and CACNG8] are down-regulated in clozapine-responsive SCZ neurons, in which some are restored by clazopine (Hribkova et al., 2022). Those studies suggest that the dysregulation of ion channel genes is associated with SCZ. Understanding the role of individual channels in SCZ is an insurmountable task due to the numerous constellations of subtypes. Therefore, computing and mathematical modeling would be useful tools to explore the involvement of ion channels in SCZ and for drug testing. In this Research Topic, Rathour and Kaphzan employ neuronal modeling to compute how variability of voltage-gated ion channels (VGICs), including fast Na+, delayed rectifier K+, A-type K+, T-type Ca++, and HCN channels, affects information transfer in neurons. They show that the A-type K+ channel is the major regulator of information transfer. McGahan and Keener construct a novel mathematical model for heteromeric potassium channels that captures both α-subunit number and type present in each channel.
At the cell-type level, a review article by Apicella and Marchionni elucidate the role of vasoactive intestinal polypeptide (VIP)-expressing GABAergic neurons in the neocortical areas via disinhibitory and inhibitory effects on the intricate cortical circuits, which translates the external stimuli into underlying behaviors. The authors mentioned the effect of ErbB4 knockout mice on cortical microcircuits. ErbB4 ablation reduces the activity of VIP-expressing neurons also witnessed with an increase excitatory neuronal activity, suggesting a direct inhibitory effect of the VIP (Batista-Brito et al., 2017). ErbB4, a receptor of the schizophrenia-linked protein neuregulin-1, regulates glutamatergic synapse maturation, plasticity, NMDAR-mediated neurotransmission, and the migration of GABAergic interneurons (Flames et al., 2004; Li et al., 2007). The dopaminergic system plays a crucial role in the pathophysiology of schizophrenia (Collo et al., 2020; Martel and Gatti McArthur, 2020; Sonnenschein et al., 2020). It will be of interest to delineate the abnormalities in SCZ patient-specific dopaminergic neurons at the molecular and cellullar levels. Rakovic et al. generate a TH-mCherry iPSC reporter line by CRISPR/Cas9 technology to enrich the population of electrophysiologically mature TH+ dopaminergic neurons. This method can be applied to SCZ patient-specific iPSC lines for underpinning the dysfunction of dopaminergic neurons.
At the regional level, limbic regions such as the hippocampus and amygdala are known to play a role in working memory processes, but the relationship between structural changes in these regions and cognitive deficits in schizophrenia is complex and influenced by various factors, including the severity of the condition. Three articles in this Research Topic provide new insights into this issue. Cheng et al. suggest that the disrupted integration of the default mode network (DMN) contributes to working memory deficits in SCZ patients with severe attention problems. They use graph theory to examine the network topology of the brain during a working memory task and at rest in SCZ patients with different levels of attention deficit severity. The results show that patients with severe attention deficits have a higher normalized path length of the DMN compared to those with mild attention deficits and healthy controls, which are not sustained during rest. These findings might provide reliable biomarkers for attention deficits during working memory tasks for schizophrenia patients. Peterson et al. show that structural atrophy in the head and tail of the hippocampus and widespread amygdala positively correlated with the severity of symptoms and inversely with working memory performance in SCZ patients. They suggest that patients in different severity groups might form a spectrum of severity, as their working memory deficits and brain structural abnormalities follow similar patterns, but with varying degrees of severity. Delgado-Sallent et al. adopted a phencyclidine (PCP) mouse model to investigate the effects of NMDAR hypofunction on neural activities in the medial prefrontal cortex (mPFC) and the dorsal hippocampus (dHPC) during memory acquisition. They find that mice with subchronic PCP treatments exhibit impairments in short-term and long-term memory, which is associated with the disrupted mPFC-dHPC connectivity and the memory deficits are alleviated with Risperidone treatments by targeting this circuit. They suggest that this phenomenon might apply to SCZ patients with NMDAR hypofunction. An extracellular matrix protein Reelin is associated with SCZ in the human and mouse (Fatemi et al., 2001; Ishii et al., 2016; Negrón-Oyarzo et al., 2016). In this Research Topic, Pardo et al. report the effects of Reelin levels on adult brain's striatal structure and neuronal composition. They show that Reelin knockout mice (Cre fR/fR) from p45-60 onwards do not exhibit aberrant striatal structure and neuronal composition, whereas Reelin overexpressing (TgRln) mice display increases in the densities of striatal cholinergic interneurons and Parvalbumin interneurons in the ventral-medial striatum, dopaminergic projections in the ventral striatum, the number of dopaminergic synaptic boutons in the NAcc. They suggest those effects might play a counteracting role in the excitatory/inhibitory imbalance.
In closing, each SCZ study provides a piece of the puzzle. When many pieces of the puzzle fall into place, the pathophysiology of SCZ will be apparent. We hope that day is coming soon.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
This work was funded by the STI2030-Major Projects (No. 2022ZD0214000 [to JC]), the National Key R&D Program of China (No. 2021YFC2502200 [to JC]), and the National Natural Science Foundation of China (No. 82201658 [to JC]).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Batista-BritoR.VinckM.FergusonK. A.ChangJ. T.LaubenderD.LurG.et al. (2017). Developmental dysfunction of VIP interneurons impairs cortical circuits. Neuron95, 884–895.e889. 10.1016/j.neuron.2017.07.034
2
BelmerA.LanoueV.PatkarO. L.BartlettS. E. (2016). Excitatory/inhibitory balance of serotonergic axon connectivity in the brain. J. Neurol. Neuromed.1, 18–22. 10.29245/2572.942X/2016/9.1079
3
BurkeK. J.Jr.BenderK.J. (2019). Modulation of ion channels in the axon: mechanisms and function. Front. Cell. Neurosci.13, 221. 10.3389/fncel.2019.00221
4
CasanovaM. F.SwitalaA. E.TrippeJ.FitzgeraldM. (2007). Comparative minicolumnar morphometry of three distinguished scientists. Autism11, 557–569. 10.1177/1362361307083261
5
ColloG.MucciA.GiordanoG. M.Merlo PichE.GalderisiS. (2020). Negative symptoms of schizophrenia and dopaminergic transmission: translational models and perspectives opened by iPSC techniques. Front. Neurosci.14, 632. 10.3389/fnins.2020.00632
6
CoyleJ. T. (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Riv. Psichiatr.3, 241–253. 10.3109/10673229609017192
7
Di BiaseM. A.CropleyV. L.CocchiL.FornitoA.CalamanteF.GanellaE. P.et al. (2019). Linking cortical and connectional pathology in schizophrenia. Schizophr. Bull.45, 911–923. 10.1093/schbul/sby121
8
EgertonA.GraceA. A.StoneJ.BossongM. G.SandM.McGuireP.et al. (2020). Glutamate in schizophrenia: neurodevelopmental perspectives and drug development. Schiz. Res.223, 59–70. 10.1016/j.schres.2020.09.013
9
FatemiS. H.KrollJ. L.StaryJ. M. (2001). Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport12, 3209–3215. 10.1097/00001756-200110290-00014
10
FlamesN.LongJ. E.GarrattA. N.FischerT. M.GassmannM.BirchmeierC.et al. (2004). Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron44, 251–261. 10.1016/j.neuron.2004.09.028
11
FristonK. (2023). Computational psychiatry: from synapses to sentience. Mol. Psychiatry28, 256–268. 10.1038/s41380-022-01743-z
12
GaoR.PenzesP. (2015). Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr. Mol. Med.15, 146–167. 10.2174/1566524015666150303003028
13
HarrisK. D.ShepherdG. M. (2015). The neocortical circuit: themes and variations. Nat. Neurosci.18, 170–181. 10.1038/nn.3917
14
Hayashi-TakagiA. (2017). Synapse pathology and translational applications for schizophrenia. Neurosci. Res.114, 3–8. 10.1016/j.neures.2016.09.001
15
HribkovaH.SvobodaO.BarteckuE.ZelinkovaJ.HorinkovaJ.LacinovaL.et al. (2022). Clozapine reverses dysfunction of glutamatergic neurons derived from clozapine-responsive schizophrenia patients. Front. Cell. Neurosci.16, 830757. 10.3389/fncel.2022.830757
16
ImbriciP.CamerinoD. C.TricaricoD. (2013). Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Front. Genet. 4, 76. 10.3389/fgene.2013.00076
17
IshiiK.KuboK.-I.NakajimaK. (2016). Reelin and neuropsychiatric disorders. Front. Cell. Neurosci.10, 229. 10.3389/fncel.2016.00229
18
LambertJ. T.HillT. C.ParkD. K.CulpJ. H.ZitoK. (2017). Protracted and asynchronous accumulation of PSD95-family MAGUKs during maturation of nascent dendritic spines. Dev. Neurobiol.77, 1161–1174. 10.1002/dneu.22503
19
LiB.WooR. S.MeiL.MalinowR. (2007). The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron54, 583–597. 10.1016/j.neuron.2007.03.028
20
LismanJ. (2012). Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?Curr. Opin. Neurobiol.22, 537–544. 10.1016/j.conb.2011.10.018
21
LiuY.OuyangP.ZhengY.MiL.ZhaoJ.NingY.et al. (2021). A selective review of the excitatory-inhibitory imbalance in schizophrenia: underlying biology, genetics, microcircuits, and symptoms. Front. Cell Dev. Biol.9, 664535. 10.3389/fcell.2021.664535
22
LodatoS.ArlottaP. (2015). Generating neuronal diversity in the mammalian cerebral cortex. Annu. Rev. Cell Dev. Biol.31, 699–720. 10.1146/annurev-cellbio-100814-125353
23
MarinO. (2012). Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci.13, 107–120. 10.1038/nrn3155
24
MartelJ. C.Gatti McArthurS. (2020). Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia. Front. Pharmacol.11, 1003. 10.3389/fphar.2020.01003
25
MoghaddamB. (2003). Bringing order to the glutamate chaos in schizophrenia. Neuron40, 881–884. 10.1016/S0896-6273(03)00757-8
26
MusallS.SunX. R.MohanH.AnX.GlufS.LiS. J.et al. (2023). Pyramidal cell types drive functionally distinct cortical activity patterns during decision-making. Nat. Neurosci.26, 495–505. 10.1038/s41593-022-01245-9
27
Negrón-OyarzoI.Lara-VásquezA.Palacios-GarcÃaI.FuentealbaP.AboitizF. (2016). Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior. Biol. Res.49, 16. 10.1186/s40659-016-0076-5
28
Obi-NagataK.TemmaY.Hayashi-TakagiA. (2019). Synaptic functions and their disruption in schizophrenia: from clinical evidence to synaptic optogenetics in an animal model. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci.95, 179–197. 10.2183/pjab.95.014
29
OprisI.CasanovaM. F. (2014). Prefrontal cortical minicolumn: from executive control to disrupted cognitive processing. Brain137, 1863–1875. 10.1093/brain/awt359
30
ParnanzoneS.SerroneD.RossettiM. C.D'OnofrioS.SplendianiA.MicelliV.et al. (2017). Alterations of cerebral white matter structure in psychosis and their clinical correlations: a systematic review of diffusion tensor imaging studies. Riv. Psichiatr.52, 49–66. 10.1708/2679.27441
31
PazR. D.TarditoS.AtzoriM.TsengK. Y. (2008). Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur. Neuropsychopharmacol.18, 773–786. 10.1016/j.euroneuro.2008.06.005
32
SelemonL. D. (2001). Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr. Bull.27, 349–377. 10.1093/oxfordjournals.schbul.a006881
33
SelemonL. D.ZecevicN. (2015). Schizophrenia: a tale of two critical periods for prefrontal cortical development. Transl. Psychiatry5, e623. 10.1038/tp.2015.115
34
SmithK. R.JonesK. A.KopeikinaK. J.BuretteA. C.CopitsB. A.YoonS.et al. (2017). Cadherin-10 maintains excitatory/inhibitory ratio through interactions with synaptic proteins. J. Neurosci.37, 11127–11139. 10.1523/JNEUROSCI.1153-17.2017
35
SohalV. S.RubensteinJ. L. R. (2019). Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol. Psychiatry24, 1248–1257. 10.1038/s41380-019-0426-0
36
SonnenscheinS. F.GomesF. V.GraceA.A. (2020). Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Front. Psychiatry11, 613. 10.3389/fpsyt.2020.00613
37
TattiR.HaleyM. S.SwansonO. K.TselhaT.MaffeiA. (2017). Neurophysiology and regulation of the balance between excitation and inhibition in neocortical circuits. Biol. Psychiatry81, 821–831. 10.1016/j.biopsych.2016.09.017
38
TunsetM. E.Haslene-HoxH.Van Den BosscheT.VaalerA. E.SulheimE.KondziellaD.et al. (2020). Extracellular vesicles in patients in the acute phase of psychosis and after clinical improvement: an explorative study. Peer J.8, e9714. 10.7717/peerj.9714
39
VoglisG.TavernarakisN. (2006). The role of synaptic ion channels in synaptic plasticity. EMBO Rep.7, 1104–1110. 10.1038/sj.embor.7400830
40
WangY.AmdaneeN.ZhangX. (2022). Exosomes in schizophrenia: pathophysiological mechanisms, biomarkers, and therapeutic targets. Eur. Psychiatry65, e61. 10.1192/j.eurpsy.2022.2319
41
YizharO.FennoL. E.PriggeM.SchneiderF.DavidsonT. J.O'SheaD. J.et al. (2011). Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature477, 171–178. 10.1038/nature10360
42
ZengM.ShangY.ArakiY.GuoT.HuganirR. L.ZhangM.et al. (2016). Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity. Cell166, 1163–1175.e12. 10.1016/j.cell.2016.07.008
Summary
Keywords
schizophrenia, excitation/inhibition (E/I) imbalance, extracellular vesicles (EVs), voltage-gated ion channels, (VIP)-expressing GABAergic neurons, human iPSC derived neurons, working memory (WM), Reelin
Citation
Sun Y-M and Chen J (2023) Editorial: New insights into schizophrenia-related neural and behavioral phenotypes. Front. Cell. Neurosci. 17:1202230. doi: 10.3389/fncel.2023.1202230
Received
07 April 2023
Accepted
21 April 2023
Published
10 May 2023
Volume
17 - 2023
Edited and reviewed by
Dirk M. Hermann, University of Duisburg-Essen, Germany
Updates
Copyright
© 2023 Sun and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuh-Man Sun yuhman.sun@gmail.comJi Chen ji.chen@zju.edu.cn
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.